Меню
Набор скоро начнётся NCT07391449

Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis

Без фазы С лечением Knee Osteoarthritis

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: HRV-guided home exercise prescription, Traditional Home Exercise.
Кому может быть актуально
Состояния в реестре: Knee Osteoarthritis. Базовые параметры: 45 лет — 70 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Гонконг
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Heart Rate Variability Guided Optimization of Physical Activity and Exercise Prescription to Enhance Rehabilitation Outcomes in Individuals With Knee Osteoarthritis (HOPE-OA Trial)

Обзор

The aim of this trial is to conduct a 12-week randomised controlled trial comparing an HRV-guided home exercise program with traditional home exercise program for individuals with knee osteoarthritis (KOA), followed by 24-week assessment. The trial employs a validated HRV sensor and the HRV4Training app to record daily HRV measurements, enabling personalized exercise intensity adjustments. Participants with high HRV are prescribed high-intensity exercises, while those with low HRV undertake low-intensity exercises. In contrast, the traditional exercise group follows a standardised program, progressing from low to high intensity over the 12-week period. The primary objective of this trial is to evaluate the effect of HRV-guided exercise on pain and functional disability in patients with KOA using validated outcome measures assessed at baseline, 12 weeks (post-intervention), and 24 weeks. Longitudinal semi-structured qualitative interviews at weeks 12 and 24 will explore participants' experiences and perceived barriers to exercise adherence. A mediation analysis will elucidate the physiological mechanisms underlying the efficacy of HRV-guided exercise. Secondary objectives include comparing HRV-guided and traditional home exercise programme in terms of exercise adherence, quality of life, sleep quality, self-efficacy, patient satisfaction, physical performance, balance, muscle strength, and lower limb biomechanics. Exploratory aims involve evaluating long-term effects (up to 24 weeks), examining associations between baseline HRV profiles and key outcomes, and determining the cost-effectiveness of HRV-guided exercise relative to traditional programme. The trial employs a robust methodological design, applying mixed-effects models and an intention-to-treat approach for data analysis.

Вмешательства

  • Поведенческое HRV-guided home exercise prescription
    Participants in this group will follow the same exercise structure as the traditional home exercise group; however, their exercise program will be individualised according to daily HRV profiles. Exercise sessions will be performed three times per week for 12 weeks (36 sessions). All participants will conduct HRV measurements, starting one week before the intervention and continuing until its completion. HRV will be measured each morning immediately after awakening and bladder voiding, with parti
  • Поведенческое Traditional Home Exercise
    Participants in this group will measure their HRV daily as described in the next section; however, these HRV measurements will not be used to guide their exercise prescription. Instead, participants will follow a standardized home exercise programme, conducted three sessions per week for 12 weeks (36 sessions). Each session will include a 5-10-minute warm-up, a main exercise component comprising aerobic, strengthening, and stretching exercises (e.g., stretching of lower extremity muscles includi

Первичные конечные точки

  • Knee pain [Срок оценки: change from pre- to post-treatment (12 weeks)]
  • Physical Function [Срок оценки: Change from pre- to post-treatment (12 weeks)]
Вторичные конечные точки (12)
  • Healthcare resource utilisation [Срок оценки: week 12 and week 24]
  • Quality adjusted life year (QALY) [Срок оценки: week 12 and week 24]
  • Knee pain [Срок оценки: changes from baseline to week 24]
  • Physical function [Срок оценки: changes from baseline to week 24]
  • Arthritis self-efficacy scale (ASES) [Срок оценки: Baseline, week 12, week 24]
  • Pittsburgh Sleep Quality Index [Срок оценки: Baseline, week 12, week 24]
  • Center for Epidemiologic Studies Depression Scale (CESD) [Срок оценки: Baseline, week 12, week 24]
  • Patient Specific Functional Scale (PSFS) [Срок оценки: Baseline, week 12, week 24]
  • 30 second chair stand test (30sCST) [Срок оценки: changes from baseline to week 12]
  • 40-m fast-paced walk test (40MFPW) [Срок оценки: changes from baseline to week 12]
  • Stair-climbing test (SCT) [Срок оценки: changes from baseline to week 12]
  • Gait analysis [Срок оценки: changes from baseline to week 12]

Критерии участия

Критерии включения

  • Participants will include adults aged 45 years and older with symptomatic KOA, diagnosed according to the American College of Rheumatology Clinical Criteria for the Classification and Reporting of KOA.
  • Mild to moderate KOA (Kellgren Lawrence grade ≤ grade III),
  • a body mass index (BMI) ≤ 40 kg/m2, and
  • an average knee pain intensity ≥ 3 on a 0-10 numerical rating scale during the past week.

Критерии исключения

  • presence of neurological disorders;
  • nonambulatory status;
  • implanted electrical devices;
  • systemic inflammatory arthritis (e.g., gout);
  • significant cognitive impairment;
  • prior hip or knee arthroplasty;
  • history of trauma or surgical arthroscopy of either knee within the past six months;
  • participation in a similar study within the past six months;
  • engagement in an exercise programme within the past six months;
  • receipt of knee intra-articular injection within the past three months;
  • current anticoagulant therapy;
  • recent or planned surgery within three months; and
  • any medical comorbidities precluding safe participation in exercise.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Тройное слепое
Основная цель
Лечение

Центры проведения

Гонконг · 1 центр
  • Department of Rehabilitation Sciences, The Hong Kong Polytechnic University — Kowloon

Публикации

  • 37. Saldaña J. Longitudinal qualitative research: analyzing change through time. Bloomsbury Publishing PLC; 2003 May 16.
  • 36. Plano Clark VL, Schumacher K, West C, Edrington J, Dunn LB, Harzstark A, Melisko M, Rabow MW, Swift PS, Miaskowski C. Practices for embedding an interpretive qualitative approach within a randomized clinical trial. Journal of Mixed Methods Research. 2013 Jul;7(3):219-42.
  • 35. Winser SJ, Pang M, Whitney S, Chan AY, Chen C. Cost and effectiveness of Dual-task training on balance and fall risk in individuals with cerebellar ataxia: A randomized controlled trial. Physiotherapy. 2024 Jun 1;123:e113.
  • 34. LaFlair GT, Egbert J, Plonsky L. A practical guide to bootstrapping descriptive statistics, correlations, t tests, and ANOVAs. Advancing quantitative methods in second language research. 2015 Jul 3;46.
  • 33. Lewis JR. The system usability scale: past, present, and future. International Journal of Human-Computer Interaction. 2018 Jul 3;34(7):577-90.
  • Vesterinen V, Hakkinen K, Laine T, Hynynen E, Mikkola J, Nummela A. Predictors of individual adaptation to high-volume or high-intensity endurance training in recreational endurance runners. Scand J Med Sci Sports. 2016 Aug;26(8):885-93. doi: 10.1111/sms.12530. Epub 2015 Aug 6. PMID 26247789
  • Plews DJ, Scott B, Altini M, Wood M, Kilding AE, Laursen PB. Comparison of Heart-Rate-Variability Recording With Smartphone Photoplethysmography, Polar H7 Chest Strap, and Electrocardiography. Int J Sports Physiol Perform. 2017 Nov 1;12(10):1324-1328. doi: 10.1123/ijspp.2016-0668. Epub 2017 Dec 22. PMID 28290720
  • 30. Williams N. The Borg rating of perceived exertion (RPE) scale. Occupational medicine. 2017 Jul 1;67(5):404-5.

Идентификаторы

NCT: NCT07391449 · HSEARS20251219004

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗